RankingsPricing
  1. JP-listed companies
  2. JCR Pharmaceuticals Co.,Ltd.
  3. Financials
  4. Cost of revenue

JCR Pharmaceuticals Co.,Ltd.【JP:4552】

Market cap
¥91.7B
P/E ratio
29.2x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCost of revenue (Million JPY)YoY (%)
Mar 31, 202511,333-2.47%
Mar 31, 202411,620+30.77%
Mar 31, 20238,886-15.06%
Mar 31, 202210,461+33.91%
Mar 31, 20217,812-1.13%
Mar 31, 20207,901+20.31%
Mar 31, 20196,567+7.16%
Mar 31, 20186,128+6.91%
Mar 31, 20175,732-11.27%
Mar 31, 20166,459+12.52%
Mar 31, 20155,741

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)